STATE STREET CORP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,513,451
-75.3%
4,500,000
-75.8%
0.00%
-100.0%
Q4 2022$18,285,228
+101.1%
18,600,000
+100.0%
0.00%0.0%
Q3 2022$9,092,000
+7.2%
9,300,000
+6.3%
0.00%0.0%
Q2 2022$8,481,000
-12.0%
8,750,000
-11.2%
0.00%
Q1 2022$9,636,000
-11.7%
9,850,000
-10.5%
0.00%
-100.0%
Q4 2021$10,909,000
+11.8%
11,000,000
+11.1%
0.00%0.0%
Q3 2021$9,754,000
-5.0%
9,900,000
-4.8%
0.00%0.0%
Q2 2021$10,266,000
-6.1%
10,400,000
-8.0%
0.00%0.0%
Q1 2021$10,934,000
+30.8%
11,300,000
+27.7%
0.00%0.0%
Q4 2020$8,358,000
+2.0%
8,850,0000.0%0.00%0.0%
Q3 2020$8,195,000
-6.2%
8,850,000
-10.6%
0.00%0.0%
Q2 2020$8,740,000
-9.8%
9,900,000
-16.8%
0.00%0.0%
Q1 2020$9,689,000
-8.1%
11,900,000
+2.4%
0.00%0.0%
Q4 2019$10,548,000
-2.7%
11,625,0000.0%0.00%0.0%
Q3 2019$10,837,000
-3.9%
11,625,000
+0.9%
0.00%0.0%
Q2 2019$11,276,00011,525,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Opti Capital Management, LP 45,402,000$45,147,0003.42%
Ayrton Capital LLC 2,000,000$1,982,0001.87%
Radcliffe Capital Management, L.P. 69,010,000$68,018,0001.78%
TENOR CAPITAL MANAGEMENT Co., L.P. 74,027,000$73,675,0001.54%
DeepCurrents Investment Group LLC 33,182,000$32,736,0001.02%
Penn Mutual Asset Management 675$665,0000.71%
SHENKMAN CAPITAL MANAGEMENT INC 7,897,000$7,533,0000.51%
OAKTREE CAPITAL MANAGEMENT LP 19,901,000$19,714,0000.22%
WOLVERINE ASSET MANAGEMENT LLC 9,940,000$9,858,0000.09%
Jefferies Group LLC 12,740,000$12,658,2850.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders